Drug Database
Back to search

United Kingdom· GB-APID-36618011000001106

Levobupivacaine 125mg/100ml (0.125%) infusion bags

A levobupivacaine product containing levobupivacaine, registered in United Kingdom by Fresenius Kabi Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC N01BB10

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLevobupivacaine 125mg/100ml (0.125%) …ATCN01BB10REGISTER NO.GB-APID-3661801100000…PACKS LISTED2CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levobupivacaineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levobupivacaine is registered in 10 of 19 countries.

Countries holding a registration under ATC N01BB10 (levobupivacaine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose
Search levobupivacaine products by name

Levobupivacaine · ATC N01BB10

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Levobupivacaine
Manufacturer
Fresenius Kabi Ltd
Country
United Kingdom (GB)
ATC code
N01BB10
ATC class
Levobupivacaine
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5018750001111
  • gtin
    05018750001487

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

101 interactions on record for levobupivacaine.

Graded by severity as the source publishes them — 73 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levobupivacaine against other medicinesHow interaction checks work

Levobupivacaine · interactions on record

101 records

  • 73 moderate
  • 28 minor

Most severe, free to view

  • ClotrimazoleA01AB18moderate
  • LidocainA01AE01moderate
  • CimetidineA02BA01moderate
  • AprepitantA04AD12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levobupivacaine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levobupivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Levobupivacaine Fresenius Kabi
  • Czechia · Levobupivacaine Kabi
  • Spain · Levobupivacaína Altan, Levobupivacaína Kabi
  • France · Levobupivacaine Altan, Levobupivacaine Kabi
  • Croatia · Levobupivakain Kabi
  • Ireland · Levobupivacaine
  • Italy · Levobupivacaina Altan, Levobupivacaina Bioindustria L.I.M
  • Netherlands · Levobupivacaïne Fresenius Kabi, Levobupivacaïne Molteni
  • Poland · Levobupivacaine Molteni
  • Portugal · Levobupivacaína Altan, Levobupivacaína Kabi
  • Sweden · Levobupivacaine Molteni
  • Slovenia · Levobupivakain Kabi
  • Slovakia · Levobupivacaine Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2aa80d5-2740-4c55-9304-af1760a28b5c
GET /v1/drugs/d2aa80d5-2740-4c55-9304-af1760a28b5c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "36618011000001106",
  "desc": "Levobupivacaine 125mg/100ml (0.125%) infusion bags (Fresenius Kabi Ltd)",
  "form": "Infusion",
  "vpid": "35895711000001105",
  "source": "dmd",
  "vtm_id": "776511006",
  "strength": "1.25 mg",
  "substance": "Levobupivacaine",
  "ingredient": "Levobupivacaine hydrochloride",
  "supplier_code": "3515701000001104"
}
API referenceMCP serverPlans

See everything about levobupivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console